ArticleCell communication and signaling : CCS2024

Discovery of a novel small molecule as CD47/SIRPα and PD-1/PD-L1 dual inhibitor for cancer immunotherapy.

Shengzhe Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.